Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2WV2

X-ray structure of CYP51 from the human pathogen Trypanosoma brucei in complex with fluconazole

Summary for 2WV2
Entry DOI10.2210/pdb2wv2/pdb
Related2WUZ 2WX2
DescriptorLANOSTEROL 14-ALPHA-DEMETHYLASE, 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL, PROTOPORPHYRIN IX CONTAINING FE, ... (4 entities in total)
Functional Keywordsoxidoreductase, methyltransferase, p450, iron, cyp51, metal-binding, ergosterol biosynthesis
Biological sourceTRYPANOSOMA BRUCEI
Total number of polymer chains1
Total formula weight54898.35
Authors
Chen, C.-K.,Leung, S.S.F.,Guilbert, C.,Jacobson, M.,McKerrow, J.H.,Podust, L.M. (deposition date: 2009-10-12, release date: 2009-11-10, Last modification date: 2024-05-08)
Primary citationChen, C.-K.,Leung, S.S.F.,Guilbert, C.,Jacobson, M.,Mckerrow, J.H.,Podust, L.M.
Structural Characterization of Cyp51 from Trypanosoma Cruzi and Trypanosoma Brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Plos Negl Trop Dis, 4:E651-, 2010
Cited by
PubMed Abstract: Chagas Disease is the leading cause of heart failure in Latin America. Current drug therapy is limited by issues of both efficacy and severe side effects. Trypansoma cruzi, the protozoan agent of Chagas Disease, is closely related to two other major global pathogens, Leishmania spp., responsible for leishmaniasis, and Trypansoma brucei, the causative agent of African Sleeping Sickness. Both T. cruzi and Leishmania parasites have an essential requirement for ergosterol, and are thus vulnerable to inhibitors of sterol 14alpha-demethylase (CYP51), which catalyzes the conversion of lanosterol to ergosterol. Clinically employed anti-fungal azoles inhibit ergosterol biosynthesis in fungi, and specific azoles are also effective against both Trypanosoma and Leishmania parasites. However, modification of azoles to enhance efficacy and circumvent potential drug resistance has been problematic for both parasitic and fungal infections due to the lack of structural insights into drug binding.
PubMed: 20386598
DOI: 10.1371/JOURNAL.PNTD.0000651
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

227561

數據於2024-11-20公開中

PDB statisticsPDBj update infoContact PDBjnumon